Trident Lifeline Ltd. (TLL): Trident Lifeline Share Price Rises 9.6%: What the Move Shows
- September 22, 2026
- Posted by: Harsh Piplani
- Category: News
Trident Lifeline Share Price rose to Rs 404 today, up 9.6% from the previous close of Rs 368.6, while the company’s market capitalisation stood at Rs 376.71 Cr. The move places Trident Lifeline Ltd. in focus in Healthcare and Pharmaceuticals & Drugs, with the latest Trident Lifeline Share Price Today action supported by a clear same-day gain rather than by any stated company-specific trigger.
The stock opened at Rs 375, touched a high of Rs 412.2 and a low of Rs 368.6 during the session, and finished above the previous close. Trident Lifeline Stock News therefore centres on the verified price rise, turnover of Rs 2.18 Cr and the absence of a supplied catalyst. For readers tracking Trident Lifeline Share News, Univest notes the event as a factual market move that should be read alongside valuation, sector positioning and business fundamentals. Investors following Trident Lifeline Share Price Update can next watch whether the move is accompanied by fresh corporate disclosures, results or broader sector moves.
Trident Lifeline Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 404 |
| Previous Close | Rs 368.6 |
| Today's Move | Rs 35.4 (+9.6%) |
| Open | Rs 375 |
| High | Rs 412.2 |
| Low | Rs 368.6 |
| Turnover | Rs 2.18 crore |
| Market Capitalisation | Rs 376.71 crore |
| Market Cap Category | Micro Cap |
Trident Lifeline Ltd. (TLL) rose to Rs 404 from the previous close of Rs 368.6, a move of Rs 35.4 or 9.6%. The stock opened at Rs 375, reached a high of Rs 412.2, recorded a low of Rs 368.6.
Trident Lifeline Share Price Today shows a clear same-day rise of Rs 35.4, or 9.6%, from Rs 368.6 to Rs 404. The session range of Rs 368.6 to Rs 412.2 indicates that the stock traded across a fairly wide span before closing near the upper part of the day’s range. The opening price of Rs 375 also sat below the final close, which keeps the focus on the actual session path rather than any unsupported explanation. In plain terms, Trident Lifeline Stock Performance improved on the day in price terms, and the market data confirms the move without establishing a company-specific catalyst. For anyone scanning Stocks in News or Top Gainers Today, the important fact is the verified share price rise itself and the Rs 2.18 Cr turnover recorded alongside it.
Trident Lifeline Ltd. (TLL) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 376.71 crore |
| P/E Ratio | 23.15x |
| P/B Ratio | 4.47x |
| ROE | 18.78% |
| ROCE | 19.17% |
| EPS | Rs 15.92 |
| Book Value Per Share | Rs 82.4 |
| Dividend Yield | 0% |
Trident Lifeline Ltd. (TLL) fundamental metrics show P/E 23.15x, P/B 4.47x, ROE 18.78%, ROCE 19.17%. These figures provide context only and are not a buy or sell signal.
Trident Lifeline Ltd. has a market capitalisation of Rs 376.71 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 23.15x, P/B at 4.47x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.78% and ROCE of 19.17%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 15.92, book value per share of Rs 82.4, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.62x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 23.15x |
| Benchmark Median P/E | 32.62x |
| Benchmark Average P/E | 49.51x |
| Benchmark P/E Range | 3.37x to 747.32x |
| Company P/B Ratio | 4.47x |
| Benchmark Median P/B | 3x |
| Company ROE | 18.78% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 19.17% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 376.71 crore |
| Benchmark Median Market Cap | Rs 746.45 crore |
Trident Lifeline Ltd. (TLL) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Trident Lifeline Ltd. (TLL) has a P/E ratio of 23.15x, which is below the benchmark median of 32.62x, a difference of -29.03%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Trident Lifeline Ltd. (TLL) has a ROE of 18.78%, which is above the benchmark median of 11.74%, a difference of +59.97%. Trident Lifeline Ltd. (TLL) has a ROCE of 19.17%, which is above the benchmark median of 13.63%, a difference of +40.65%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 37.05 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.6 | 14.18 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 86.64 | 21.05 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.67 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 33.19 | 3.18 | 11.83 | 16 |
Trident Lifeline Ltd. (TLL) has a P/E ratio of 23.15x compared with the displayed peer median of 37.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.78% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 19.17% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Trident Lifeline Ltd. (TLL) has a market capitalisation of Rs 376.71 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Trident Lifeline
- Trident Lifeline Share Price rose 9.6% today to Rs 404 from Rs 368.6.
- The day’s high was Rs 412.2, while the low was Rs 368.6.
- Market capitalisation stood at Rs 376.71 Cr.
- P/E is 23.15 and P/B is 4.47, which places the stock in a clear valuation frame.
- ROE of 18.78% and ROCE of 19.17% are above the same-industry median.
About Trident Lifeline
Trident Lifeline Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. Based on the supplied sector classification, the company belongs to a business area that typically focuses on medicines and related healthcare products, and its current financial profile is best read through the available market and profitability metrics rather than through unsupported business claims. The company’s market capitalisation is Rs 376.71 Cr, while its earnings per share stand at Rs 15.92 and book value per share is Rs 82.4. These figures help place the business in a factual investment context.
The company’s return ratios, with ROE at 18.78% and ROCE at 19.17%, suggest that the reported capital base is generating respectable returns relative to the supplied sector benchmark. Its P/E of 23.15 and P/B of 4.47 provide the market’s current valuation frame. For readers tracking Trident Lifeline Company News or Trident Lifeline Stock News, the key point is that the day’s move should be viewed alongside these verified financial inputs, not separately from them. Univest keeps the company profile focused on what is known from the supplied data.
Track Trident Lifeline Share Price on Univest
Use Trident Lifeline Ltd. (TLL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Trident Lifeline Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers follow Trident Lifeline Share Price Live, Trident Lifeline Financial Results and Trident Lifeline Stock Analysis in one place, using the same verified data framework applied in this article.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Trident Lifeline Share Price rise today?
Ans. Trident Lifeline Share Price rose 9.6% today, but the supplied data does not establish a company-specific catalyst. The verified event is the price rise itself, alongside Rs 404 as the close and Rs 376.71 Cr as market capitalisation.
What is Trident Lifeline Share Price today?
Ans. Trident Lifeline Share Price today is Rs 404. It gained Rs 35.4 from the previous close of Rs 368.6, and the session also recorded a high of Rs 412.2 and a low of Rs 368.6.
Is Trident Lifeline a top gainer today?
Ans. On the supplied data, Trident Lifeline is a notable riser today with a 9.6% gain. The article describes the verified move factually, without making broader market claims beyond the session numbers.
What does Trident Lifeline market cap show?
Ans. Trident Lifeline’s market capitalisation is Rs 376.71 Cr. That places it below the same-industry median of Rs 746.45 Cr in the supplied benchmark, giving investors a clear size reference for comparison.
How does Trident Lifeline compare on valuation?
Ans. Trident Lifeline trades at a P/E of 23.15 and a P/B of 4.47. Its P/E is below the industry median of 32.62, while its P/B sits above the median of 3 in the same-industry set.
What do Trident Lifeline EPS and book value mean?
Ans. Trident Lifeline reports EPS of Rs 15.92 and book value of Rs 82.4. EPS reflects earnings attributable to each share, while book value shows the accounting net worth behind each share.
How strong are Trident Lifeline profitability ratios?
Ans. Trident Lifeline’s ROE is 18.78% and ROCE is 19.17%. Both are above the same-industry medians of 11.74% and 13.63%, which gives the stock useful profitability context. ROE stands at 18.78%.
Does Trident Lifeline pay a dividend?
Ans. The supplied dividend yield is 0. That means the current data does not show a cash dividend yield, so the stock’s market view is being shaped more by price, earnings and returns than by payout data.
